Executive summary: SecureBio is working on biosecurity projects to mitigate risks from engineered pathogens and the potential threat of AI systems creating bioweapons, using a Delay/Detect/Defend framework and collaborating with AI companies on risk evaluation.
Key points:
SecureBio’s Delay/Detect/Defend framework aims to avert engineered pathogen threats through gene synthesis screening (Delay), early pathogen detection via metagenomics (Detect), and Far-UVC research for transmission protection (Defend).
SecureBio is collaborating with frontier AI companies to build evaluation tools and mitigation strategies for potential biorisk from AI systems, which is their highest marginal value-add project for fundraising.
Without SecureBio, there may be a coverage gap in addressing exponential biorisks, as other organizations like Gryphon Scientific and RAND Corporation have a different focus.
SecureBio believes AI could potentially cause large-scale harm through attacks on financial systems, weapons of mass destruction, and bioweapons, with the latter being a high-leverage way for an agentic AI to eliminate human obstacles.
This comment was auto-generated by the EA Forum Team. Feel free to point out issues with this summary by replying to the comment, andcontact us if you have feedback.
Executive summary: SecureBio is working on biosecurity projects to mitigate risks from engineered pathogens and the potential threat of AI systems creating bioweapons, using a Delay/Detect/Defend framework and collaborating with AI companies on risk evaluation.
Key points:
SecureBio’s Delay/Detect/Defend framework aims to avert engineered pathogen threats through gene synthesis screening (Delay), early pathogen detection via metagenomics (Detect), and Far-UVC research for transmission protection (Defend).
SecureBio is collaborating with frontier AI companies to build evaluation tools and mitigation strategies for potential biorisk from AI systems, which is their highest marginal value-add project for fundraising.
Without SecureBio, there may be a coverage gap in addressing exponential biorisks, as other organizations like Gryphon Scientific and RAND Corporation have a different focus.
SecureBio believes AI could potentially cause large-scale harm through attacks on financial systems, weapons of mass destruction, and bioweapons, with the latter being a high-leverage way for an agentic AI to eliminate human obstacles.
This comment was auto-generated by the EA Forum Team. Feel free to point out issues with this summary by replying to the comment, and contact us if you have feedback.